Lethality of H5N1 Influenza Virus is Linked to TGF-beta

H5N1 流感病毒的致死率与 TGF-β 有关

基本信息

项目摘要

DESCRIPTION (provided by applicant): The current H5N1 influenza outbreak in Asia is associated with 32 human infections and approximately a 70% mortality rate. Human infections may continue to increase given the uncontrolled outbreak in poultry throughout Asia. The first documented instance of human H5N1 infection by a purely avian H5N1 strain occurred in Hong Kong in 1997. The use of these viruses increased our understanding of the viral genetics underlying influenza virulence. However, the cellular, immunological, and pathological basis for the unusual severity remains unexplored. Limited studies in animal models demonstrated that the virulent 1997 H5N1 viruses resulted in severe respiratory lesions and depression of lymphocytes. Further studies are required to determine the cellular/host mechanism of increased virulence. We demonstrated that an important difference amongst the 1997 H5N 1 viruses is the ability to activate transforming growth factor-beta (TGF-beta). TGF-beta is a potent immunomodulatory factor that influences the host response to numerous infectious diseases, including influenza. The H5N1 viruses associated with human lethality do not activate TGF-beta. Further, neutralization of TGF-beta during non-lethal H5N1 infection resulted in lethal disease characterized by decreased apoptosis in the lung, delayed viral clearance, and leukopenia. When considered together, these results suggested that TGF-beta induction might be a critical factor in influenza pathogenesis. Thus, the long-term goal of these studies is to define the mechanism of H5N1 virulence and the role of TGF-beta in protection. The specific aims are: 1. Isolate the region of influenza neuraminidase required for TGF-beta activation and determine the mechanism of activation. 2. Evaluate the requirement for TGF-beta in protection from lethal infection. 3. Examine the innate and adaptive immune responses to H5N1 influenza infection to define the mechanism of enhanced virulence. These studies provide a unique opportunity to understand the cellular and immunological basis of H5N1 influenza virus virulence in mammals: currently, an unexplored area of investigation.
描述(由申请人提供):目前在亚洲爆发的H5N1流感与32例人类感染有关,死亡率约为70%。鉴于整个亚洲家禽中不受控制的暴发,人类感染可能继续增加。香港于1997年首次出现人类感染纯禽类H5N1病毒株的病例。这些病毒的使用增加了我们对流感毒力背后的病毒遗传学的理解。然而,细胞,免疫学和病理基础的异常严重程度仍未被探索。在动物模型中进行的有限研究表明,1997年H5N1病毒的毒性导致严重的呼吸道病变和淋巴细胞抑制。需要进一步的研究来确定增加毒力的细胞/宿主机制。我们证明了1997年h5n1病毒之间的一个重要区别是激活转化生长因子- β (tgf - β)的能力。tgf - β是一种有效的免疫调节因子,影响宿主对包括流感在内的许多传染病的反应。与人类致死相关的H5N1病毒不会激活tgf - β。此外,在非致死性H5N1感染期间,tgf - β的中和导致致死性疾病,其特征是肺细胞凋亡减少、病毒清除延迟和白细胞减少。综合考虑,这些结果表明tgf - β诱导可能是流感发病的关键因素。因此,这些研究的长期目标是确定H5N1毒力的机制和tgf - β在保护中的作用。具体目标是:1。分离tgf - β激活所需的流感神经氨酸酶区域并确定激活机制。2. 评估对tgf - β的需求以防止致命感染。3. 检查对H5N1流感感染的先天和适应性免疫反应,以确定增强毒力的机制。这些研究为了解哺乳动物中H5N1流感病毒毒力的细胞和免疫学基础提供了独特的机会:目前,这是一个尚未探索的调查领域。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Stacey L Schultz-Cherry其他文献

Stacey L Schultz-Cherry的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Stacey L Schultz-Cherry', 18)}}的其他基金

Legacy of Obesity on Influenza and Coronavirus
肥胖对流感和冠状病毒的影响
  • 批准号:
    10516073
  • 财政年份:
    2021
  • 资助金额:
    $ 24.52万
  • 项目类别:
Legacy of Obesity on Influenza and Coronavirus
肥胖对流感和冠状病毒的影响
  • 批准号:
    10355239
  • 财政年份:
    2021
  • 资助金额:
    $ 24.52万
  • 项目类别:
Astrovirus CNS Infections
星状病毒中枢神经系统感染
  • 批准号:
    10514627
  • 财政年份:
    2021
  • 资助金额:
    $ 24.52万
  • 项目类别:
Astrovirus CNS Infections
星状病毒中枢神经系统感染
  • 批准号:
    10354903
  • 财政年份:
    2021
  • 资助金额:
    $ 24.52万
  • 项目类别:
2020 Biology of Acute Respiratory Infection Gordon Research Conference and Gordon Research Seminar
2020急性呼吸道感染生物学戈登研究大会暨戈登研究研讨会
  • 批准号:
    9913675
  • 财政年份:
    2020
  • 资助金额:
    $ 24.52万
  • 项目类别:
Do they or don't they: astrovirus-induced diarrhea
是还是不是:星状病毒引起的腹泻
  • 批准号:
    9804141
  • 财政年份:
    2018
  • 资助金额:
    $ 24.52万
  • 项目类别:
Beyond model development: murine astrovirus endogenous pathogens of laboratory mice
超越模型开发:实验小鼠的鼠星状病毒内源性病原体
  • 批准号:
    9165329
  • 财政年份:
    2016
  • 资助金额:
    $ 24.52万
  • 项目类别:
6th Orthomyxovirus Research Conference
第六届正粘病毒研究会议
  • 批准号:
    8400105
  • 财政年份:
    2012
  • 资助金额:
    $ 24.52万
  • 项目类别:
4th Orthomyxovirus Research Conference
第四届正粘病毒研究会议
  • 批准号:
    7275850
  • 财政年份:
    2007
  • 资助金额:
    $ 24.52万
  • 项目类别:
Lethality of H5N1 Influenza Virus is Linked to TGF-beta
H5N1 流感病毒的致死率与 TGF-β 有关
  • 批准号:
    7188537
  • 财政年份:
    2005
  • 资助金额:
    $ 24.52万
  • 项目类别:

相似海外基金

Immunoregulation of cellular immunity and tissue homeostasis during Chagas' disease
恰加斯病期间细胞免疫和组织稳态的免疫调节
  • 批准号:
    10448950
  • 财政年份:
    2022
  • 资助金额:
    $ 24.52万
  • 项目类别:
Gingival vaccination strategy to induce both humoral and cellular immunity ideal for elderly vaccination
诱导体液和细胞免疫的牙龈疫苗接种策略非常适合老年人疫苗接种
  • 批准号:
    22K09932
  • 财政年份:
    2022
  • 资助金额:
    $ 24.52万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
mRNA encoding of immune receptor-targeting antibodies for the augmentation of vaccine-elicited cellular immunity.
编码免疫受体靶向抗体的 mRNA,用于增强疫苗引发的细胞免疫。
  • 批准号:
    10508093
  • 财政年份:
    2022
  • 资助金额:
    $ 24.52万
  • 项目类别:
From mtDNA stress to cellular immunity: Triggers, Mechanisms and Effectors
从线粒体DNA应激到细胞免疫:触发因素、机制和效应器
  • 批准号:
    10501418
  • 财政年份:
    2022
  • 资助金额:
    $ 24.52万
  • 项目类别:
From mtDNA stress to cellular immunity: Triggers, Mechanisms and Effectors
从线粒体DNA应激到细胞免疫:触发因素、机制和效应器
  • 批准号:
    10650823
  • 财政年份:
    2022
  • 资助金额:
    $ 24.52万
  • 项目类别:
Longitudinal SARS-CoV-2 mRNA vaccine-induced mucosal, serological, and cellular immunity in children and human milk
纵向 SARS-CoV-2 mRNA 疫苗诱导儿童和母乳中的粘膜、血清学和细胞免疫
  • 批准号:
    10568736
  • 财政年份:
    2022
  • 资助金额:
    $ 24.52万
  • 项目类别:
SHINING A LIGHT ON BAT CELLULAR IMMUNITY FOLLOWING VIRUS INFECTION
揭示病毒感染后蝙蝠细胞免疫
  • 批准号:
    10449406
  • 财政年份:
    2022
  • 资助金额:
    $ 24.52万
  • 项目类别:
From mtDNA stress to cellular immunity: Triggers, Mechanisms and Effectors
从线粒体DNA应激到细胞免疫:触发因素、机制和效应器
  • 批准号:
    10797812
  • 财政年份:
    2022
  • 资助金额:
    $ 24.52万
  • 项目类别:
Longitudinal SARS-CoV-2 mRNA vaccine-induced mucosal, serological, and cellular immunity in children and human milk
纵向 SARS-CoV-2 mRNA 疫苗诱导儿童和母乳中的粘膜、血清学和细胞免疫
  • 批准号:
    10895221
  • 财政年份:
    2022
  • 资助金额:
    $ 24.52万
  • 项目类别:
mRNA encoding of immune receptor-targeting antibodies for the augmentation of vaccine-elicited cellular immunity.
编码免疫受体靶向抗体的 mRNA,用于增强疫苗引发的细胞免疫。
  • 批准号:
    10662571
  • 财政年份:
    2022
  • 资助金额:
    $ 24.52万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了